Abstract
Ropinirole is a non-ergolinic dopamine agonist, which has been used for over 10 years for the treatment of Parkinson’s disease. A new formulation (PR = prolonged release) has been developed, which allows the drug to be released slowly (continuously) so that it only has to be given once daily. Switching from the previous ropinirole immediate release ( ropinirole IR) to the prolonged release (ropinirole PR) formulation at the nearest equivalent total daily dose, can take place overnight and the acceptance and tolerability are good. The advantages are once-daily dosing, faster titration with good tolerability and more stable plasma levels. The new formulation is regarded as valuable addition to the currently available medications.
Similar content being viewed by others
References
Tompson DJ, Vearer D (2007) Steady-State Pharmacokinetic Properties of a 24-hour Prolonged-Release Formulation of Ropinirole: Results of Two Randomised Studies in Patients with Parkinson’s Disease. Clin Therapeutics 29(12):2654–2666
Stocchi F, Giorgi L (2006) Efficacy of ropinirole 24-hour prolonged release compared with immediate release formulation in early Parkinson’s disease (PD): the EASE-PD Monotherapy study. Eur J Neurology 13(Suppl. 2):205
Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, Elmer LW, Truong DD, Earl NL, on behalf of the EASE-PD Adjunct Study Investigators (2007) Ropinirole 24-hour prolonged release. Randomized, controlled study in advanced Parkinson disease. Neurology 68:1108–1115
Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Högl B, Trenkwalder C (2002) The Parkinson Disease Sleep Scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73:629–635
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jost, W.H., Buhmann, C., Fuchs, G. et al. Initial experience with ropinirole PR (prolonged release). J Neurol 255 (Suppl 5), 60–63 (2008). https://doi.org/10.1007/s00415-008-5008-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-5008-z